天津医药 ›› 2017, Vol. 45 ›› Issue (7): 719-722.doi: 10.11958/20170552

• 临床研究 • 上一篇    下一篇

布地奈德雾化佐治小儿气管插管拔管后的临床疗效观察

郭永盛,邹映雪,沈阳   

  1. 天津市儿童医院感染及呼吸二科 (邮编 300134)
  • 收稿日期:2017-05-10 修回日期:2017-06-22 出版日期:2017-07-15 发布日期:2017-08-08
  • 通讯作者: 邹映雪 E-mail:xue11235813@163.com

Clinical observation of the effect of budesonide atomization on tracheal extubation in children

GUO Yong-sheng,ZOU Ying-xue,SHEN Yang   

  1. Department of Infectious Diseases and 2nd Department of Respiration, Tianjin Children’ s Hospital, Tianjin 300134, China
  • Received:2017-05-10 Revised:2017-06-22 Published:2017-07-15 Online:2017-08-08
  • Contact: ZOU Ying-xue E-mail:xue11235813@163.com

摘要: 目的 观察布地奈德雾化吸入佐治小儿气管插管拔管后的临床疗效。方法 收集 2013 年 5 月—2016 年9 月天津市儿童医院感染科收治的不同疾病导致气管插管患儿共 85 例, 随机分为布地奈德组 (44 例) 和地塞米松组(41 例)。布地奈德组于拔管前 30 min 予布地奈德混悬液 1 mg 雾化吸入, 拔管后立即予 1 mg 雾化吸入, 之后 4 d 每8 h 予布地奈德混悬液 0.5~1.0 mg 雾化吸入。地塞米松组于拔管前 30 min 静脉应用地塞米松 0.2~0.3 mg/kg, 拔管后立即予 2.5~5.0 mg 雾化吸入, 之后 4 d 每 8 h 予 2.5~5.0 mg 雾化吸入。比较 2 组拔管成功率, 喉水肿 (拔管后喘鸣、 声音嘶哑)发生率、 消退时间, 拔管后 24 h 内出现缺氧表现、 再次插管率以及继发感染率。结果 2 组间拔管成功率、 喉水肿发生率、 消退时间, 缺氧发生率以及再次插管率差异均无统计学意义 (P > 0.05); 地塞米松组 2 例拔管后出现继发感染。结论 布地奈德和地塞米松在防治拔管后喉水肿方面均有疗效, 布地奈德雾化可以替代全身应用糖皮质激素, 从而减少激素不良反应。推荐使用布地奈德防治气管插管拔管后不良反应。

关键词: 布地奈德, 地塞米松, 儿童, 住院, 插管法, 气管内, 治疗结果, 不良反应

Abstract: Objective To investigate the effect of budesonide atomization on tracheal extubation in children. Methods A total of 85 patients with tracheal intubation in Tianjin Children’ s Hospital from May 2013 to September 2016 were selected in this study. Patients were randomly divided into budesonide group (n=44) and dexamethasone group (n=41).The budesonide group was given 1 mg of budesonide for inhalation 30 min before extubation, and 1 mg of budesonide inhalation immediately after extubation. Then every 8 hours for 0.5- 1.0 mg budesonide inhalation for 4 days. The dexamethasone group was given dexamethasone 0.2-0.3 mg/kg intravenously 30 min before extubation, and dexamethasone 2.5-5.0 mg inhalation immediately after extubation. Then dexamethasone 2.5-5.0 mg inhalation was given every 8 hours for 4 days. The incidence of laryngeal edema (stridor, hoarseness), the time of extinction, the expression of hypoxia, reintubation rate within 24 hours and secondary infection rate after extubation were compared between the two groups.Results There were no significant differences in the mission success rate, the incidence of laryngeal edema, the time of extinction, the incidence of hypoxia and re- intubation rate between the two groups (P > 0.05). Two patients were found secondary infection after extubation in dexamethasone group. Conclusion Both budesonide and dexamethasone show curative effects on the prevention and treatment of laryngeal edema after extubation. Budesonide atomization can replace systemic corticosteroids, thus reducing the adverse reactions of glucocorticoids. We recommend the use of budesonide in treating adverse events after extubation.

Key words: budesonide, dexamethasone, child, hospitalized, intubation, intratracheal, treatment outcome, adverse reaction

中图分类号: